Article Versions Notes

Hoelzen EJ, Radomska HS, Kulp SK, Adeluola AA, Granchie LA, Cheng J, Dauki AM, Campbell MJ, Mohammed S, Xing E, et al. Valine–Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular Carcinoma. Cancers. 2025; 17(15):2535. https://doi.org/10.3390/cancers17152535

Hoelzen, Emma J., Hanna S. Radomska, Samuel K. Kulp, Adeoluwa A. Adeluola, Lauren A. Granchie, Jeffrey Cheng, Anees M. Dauki, Moray J. Campbell, Shabber Mohammed, Enming Xing, and et al. 2025. "Valine–Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular Carcinoma" Cancers 17, no. 15: 2535. https://doi.org/10.3390/cancers17152535

Hoelzen, E. J., Radomska, H. S., Kulp, S. K., Adeluola, A. A., Granchie, L. A., Cheng, J., Dauki, A. M., Campbell, M. J., Mohammed, S., Xing, E., Hai, M., Fukuda, M., Cheng, X., Phelps, M. A., Li, P.-K., & Coss, C. C. (2025). Valine–Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular Carcinoma. Cancers, 17(15), 2535. https://doi.org/10.3390/cancers17152535